Global Therapeutic Nuclear Medicines Market Professional Survey Report 2018

June 2018 | 109 pages | ID: G73D103FA79EN
QYResearch

Abstracts

This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by manufacturers, type, application, and region.
This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Therapeutic Nuclear Medicines market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report

• Cardinal Health
• Mallinckrodt
• GE Healthcare
• Lantheus Medical Imaging
• Bayer
• Bracco Imaging
• Eczacibasi-Monrol Nuclear Products
• Nordion
• Advanced Accelerator Applications
• IBA Molecular Imaging

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

The regional scope of the study is as follows:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Beta Emitters
• Alpha Emitters
• Brachytherapy Products

By Application, the market can be split into

• Thyroid
• Bone Metastasis
• Lymphoma
• Endocrine Tumors
• Others

The study objectives of this report are:

• To analyze and study the global Therapeutic Nuclear Medicines capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key Therapeutic Nuclear Medicines manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Therapeutic Nuclear Medicines Manufacturers
Therapeutic Nuclear Medicines Distributors/Traders/Wholesalers
Therapeutic Nuclear Medicines Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Therapeutic Nuclear Medicines market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Therapeutic Nuclear Medicines Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF THERAPEUTIC NUCLEAR MEDICINES

1.1 Definition and Specifications of Therapeutic Nuclear Medicines
  1.1.1 Definition of Therapeutic Nuclear Medicines
  1.1.2 Specifications of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines
  1.2.1 Beta Emitters
  1.2.2 Alpha Emitters
  1.2.3 Brachytherapy Products
1.3 Applications of Therapeutic Nuclear Medicines
  1.3.1 Thyroid
  1.3.2 Bone Metastasis
  1.3.3 Lymphoma
  1.3.4 Endocrine Tumors
  1.3.5 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines
2.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
2.4 Industry Chain Structure of Therapeutic Nuclear Medicines

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES

3.1 Capacity and Commercial Production Date of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017

4 GLOBAL THERAPEUTIC NUCLEAR MEDICINES OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Therapeutic Nuclear Medicines Capacity and Growth Rate Analysis
  4.2.2 2017 Therapeutic Nuclear Medicines Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Therapeutic Nuclear Medicines Sales and Growth Rate Analysis
  4.3.2 2017 Therapeutic Nuclear Medicines Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Therapeutic Nuclear Medicines Sales Price
  4.4.2 2017 Therapeutic Nuclear Medicines Sales Price Analysis (Company Segment)

5 THERAPEUTIC NUCLEAR MEDICINES REGIONAL MARKET ANALYSIS

5.1 North America Therapeutic Nuclear Medicines Market Analysis
  5.1.1 North America Therapeutic Nuclear Medicines Market Overview
  5.1.2 North America 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.1.4 North America 2017 Therapeutic Nuclear Medicines Market Share Analysis
5.2 Europe Therapeutic Nuclear Medicines Market Analysis
  5.2.1 Europe Therapeutic Nuclear Medicines Market Overview
  5.2.2 Europe 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.2.4 Europe 2017 Therapeutic Nuclear Medicines Market Share Analysis
5.3 China Therapeutic Nuclear Medicines Market Analysis
  5.3.1 China Therapeutic Nuclear Medicines Market Overview
  5.3.2 China 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.3.4 China 2017 Therapeutic Nuclear Medicines Market Share Analysis
5.4 Japan Therapeutic Nuclear Medicines Market Analysis
  5.4.1 Japan Therapeutic Nuclear Medicines Market Overview
  5.4.2 Japan 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.4.4 Japan 2017 Therapeutic Nuclear Medicines Market Share Analysis
5.5 Southeast Asia Therapeutic Nuclear Medicines Market Analysis
  5.5.1 Southeast Asia Therapeutic Nuclear Medicines Market Overview
  5.5.2 Southeast Asia 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.5.4 Southeast Asia 2017 Therapeutic Nuclear Medicines Market Share Analysis
5.6 India Therapeutic Nuclear Medicines Market Analysis
  5.6.1 India Therapeutic Nuclear Medicines Market Overview
  5.6.2 India 2013-2018E Therapeutic Nuclear Medicines Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Therapeutic Nuclear Medicines Sales Price Analysis
  5.6.4 India 2017 Therapeutic Nuclear Medicines Market Share Analysis

6 GLOBAL 2013-2018E THERAPEUTIC NUCLEAR MEDICINES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Therapeutic Nuclear Medicines Sales by Type
6.2 Different Types of Therapeutic Nuclear Medicines Product Interview Price Analysis
6.3 Different Types of Therapeutic Nuclear Medicines Product Driving Factors Analysis
  6.3.1 Beta Emitters of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  6.3.2 Alpha Emitters of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  6.3.3 Brachytherapy Products of Therapeutic Nuclear Medicines Growth Driving Factor Analysis

7 GLOBAL 2013-2018E THERAPEUTIC NUCLEAR MEDICINES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Therapeutic Nuclear Medicines Consumption by Application
7.2 Different Application of Therapeutic Nuclear Medicines Product Interview Price Analysis
7.3 Different Application of Therapeutic Nuclear Medicines Product Driving Factors Analysis
  7.3.1 Thyroid of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  7.3.2 Bone Metastasis of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  7.3.3 Lymphoma of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  7.3.4 Endocrine Tumors of Therapeutic Nuclear Medicines Growth Driving Factor Analysis
  7.3.5 Others of Therapeutic Nuclear Medicines Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES

8.1 Cardinal Health
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Cardinal Health 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Cardinal Health 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.2 Mallinckrodt
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Mallinckrodt 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Mallinckrodt 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.3 GE Healthcare
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GE Healthcare 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GE Healthcare 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.4 Lantheus Medical Imaging
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Lantheus Medical Imaging 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Lantheus Medical Imaging 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.5 Bayer
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Bayer 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Bayer 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.6 Bracco Imaging
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Bracco Imaging 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Bracco Imaging 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.7 Eczacibasi-Monrol Nuclear Products
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Eczacibasi-Monrol Nuclear Products 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Eczacibasi-Monrol Nuclear Products 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.8 Nordion
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Nordion 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Nordion 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.9 Advanced Accelerator Applications
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Advanced Accelerator Applications 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Advanced Accelerator Applications 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis
8.10 IBA Molecular Imaging
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 IBA Molecular Imaging 2017 Therapeutic Nuclear Medicines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 IBA Molecular Imaging 2017 Therapeutic Nuclear Medicines Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES MARKET

9.1 Global Therapeutic Nuclear Medicines Market Trend Analysis
  9.1.1 Global 2018-2025 Therapeutic Nuclear Medicines Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Therapeutic Nuclear Medicines Sales Price Forecast
9.2 Therapeutic Nuclear Medicines Regional Market Trend
  9.2.1 North America 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
  9.2.2 Europe 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
  9.2.3 China 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
  9.2.4 Japan 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
  9.2.6 India 2018-2025 Therapeutic Nuclear Medicines Consumption Forecast
9.3 Therapeutic Nuclear Medicines Market Trend (Product Type)
9.4 Therapeutic Nuclear Medicines Market Trend (Application)

10 THERAPEUTIC NUCLEAR MEDICINES MARKETING TYPE ANALYSIS

10.1 Therapeutic Nuclear Medicines Regional Marketing Type Analysis
10.2 Therapeutic Nuclear Medicines International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Therapeutic Nuclear Medicines by Region
10.4 Therapeutic Nuclear Medicines Supply Chain Analysis

11 CONSUMERS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES
Figure Picture of Therapeutic Nuclear Medicines
Table Product Specifications of Therapeutic Nuclear Medicines
Table Classification of Therapeutic Nuclear Medicines
Figure Global Production Market Share of Therapeutic Nuclear Medicines by Type in 2017
Figure Beta Emitters Picture
Table Major Manufacturers of Beta Emitters
Figure Alpha Emitters Picture
Table Major Manufacturers of Alpha Emitters
Figure Brachytherapy Products Picture
Table Major Manufacturers of Brachytherapy Products
Table Applications of Therapeutic Nuclear Medicines
Figure Global Consumption Volume Market Share of Therapeutic Nuclear Medicines by Application in 2017
Figure Thyroid Examples
Table Major Consumers in Thyroid
Figure Bone Metastasis Examples
Table Major Consumers in Bone Metastasis
Figure Lymphoma Examples
Table Major Consumers in Lymphoma
Figure Endocrine Tumors Examples
Table Major Consumers in Endocrine Tumors
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Therapeutic Nuclear Medicines by Regions
Figure North America Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Figure Europe Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Figure China Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Figure Japan Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Figure India Therapeutic Nuclear Medicines Market Size (Million USD) (2013-2025)
Table Therapeutic Nuclear Medicines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2017
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Industry Chain Structure of Therapeutic Nuclear Medicines
Table Capacity and Commercial Production Date of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Therapeutic Nuclear Medicines 2013-2018E
Figure Global 2013-2018E Therapeutic Nuclear Medicines Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Therapeutic Nuclear Medicines Market Size (Value) and Growth Rate
Table 2013-2018E Global Therapeutic Nuclear Medicines Capacity and Growth Rate
Table 2017 Global Therapeutic Nuclear Medicines Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate
Table 2017 Global Therapeutic Nuclear Medicines Sales (K Units) List (Company Segment)
Table 2013-2018E Global Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Table 2017 Global Therapeutic Nuclear Medicines Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure North America 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure North America 2017 Therapeutic Nuclear Medicines Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure Europe 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure Europe 2017 Therapeutic Nuclear Medicines Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure China 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure China 2017 Therapeutic Nuclear Medicines Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure Japan 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure Japan 2017 Therapeutic Nuclear Medicines Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure Southeast Asia 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure Southeast Asia 2017 Therapeutic Nuclear Medicines Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Therapeutic Nuclear Medicines 2013-2018E
Figure India 2013-2018E Therapeutic Nuclear Medicines Sales Price (USD/Unit)
Figure India 2017 Therapeutic Nuclear Medicines Sales Market Share
Table Global 2013-2018E Therapeutic Nuclear Medicines Sales (K Units) by Type
Table Different Types Therapeutic Nuclear Medicines Product Interview Price
Table Global 2013-2018E Therapeutic Nuclear Medicines Sales (K Units) by Application
Table Different Application Therapeutic Nuclear Medicines Product Interview Price
Table Cardinal Health Information List
Table Product A Overview
Table Product B Overview
Table 2017 Cardinal Health Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Cardinal Health Therapeutic Nuclear Medicines Business Region Distribution
Table Mallinckrodt Information List
Table Product A Overview
Table Product B Overview
Table 2017 Mallinckrodt Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Mallinckrodt Therapeutic Nuclear Medicines Business Region Distribution
Table GE Healthcare Information List
Table Product A Overview
Table Product B Overview
Table 2015 GE Healthcare Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 GE Healthcare Therapeutic Nuclear Medicines Business Region Distribution
Table Lantheus Medical Imaging Information List
Table Product A Overview
Table Product B Overview
Table 2017 Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Lantheus Medical Imaging Therapeutic Nuclear Medicines Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bayer Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer Therapeutic Nuclear Medicines Business Region Distribution
Table Bracco Imaging Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bracco Imaging Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bracco Imaging Therapeutic Nuclear Medicines Business Region Distribution
Table Eczacibasi-Monrol Nuclear Products Information List
Table Product A Overview
Table Product B Overview
Table 2017 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Business Region Distribution
Table Nordion Information List
Table Product A Overview
Table Product B Overview
Table 2017 Nordion Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Nordion Therapeutic Nuclear Medicines Business Region Distribution
Table Advanced Accelerator Applications Information List
Table Product A Overview
Table Product B Overview
Table 2017 Advanced Accelerator Applications Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Advanced Accelerator Applications Therapeutic Nuclear Medicines Business Region Distribution
Table IBA Molecular Imaging Information List
Table Product A Overview
Table Product B Overview
Table 2017 IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 IBA Molecular Imaging Therapeutic Nuclear Medicines Business Region Distribution
Figure Global 2018-2025 Therapeutic Nuclear Medicines Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Therapeutic Nuclear Medicines Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Therapeutic Nuclear Medicines Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Therapeutic Nuclear Medicines Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Therapeutic Nuclear Medicines by Type 2018-2025
Table Global Consumption Volume (K Units) of Therapeutic Nuclear Medicines by Application 2018-2025
Table Traders or Distributors with Contact Information of Therapeutic Nuclear Medicines by Region